Breaking News
July 17, 2018 - Researchers map family trees of cancer cells to understand how AML responds to new drug
July 17, 2018 - Mortality from heart failure remains higher in women than men
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
Genetic checking out is helping set secure dose of not unusual blood thinner

Genetic checking out is helping set secure dose of not unusual blood thinner

image_pdfDownload PDFimage_print

Warfarin is a blood thinner this is recurrently prescribed to sufferers to stop life-threatening blood clots. In spite of its longtime use, warfarin stays tough to dose as a result of an individual’s genetic make-up influences how the drug is processed within the frame. An excessive amount of warfarin may cause inside bleeding; too little warfarin fails to stop blood clots.

Now, a brand new find out about led via Washington College Faculty of Medication in St. Louis presentations that dosing warfarin (Coumadin and others) is more secure—generating fewer opposed occasions equivalent to hemorrhage—when key components of a affected person’s genetic make-up are regarded as.

The analysis, printed Sept. 26 within the Magazine of the American Clinical Affiliation, experiences effects from the medical trial referred to as GIFT (Genetics Informatics Trial of Warfarin to Save you Deep Venous Thrombosis).

“Physicians were prescribing warfarin because the Eisenhower management,” mentioned first writer Brian F. Gage, MD, a professor of medication at Washington College Faculty of Medication in St. Louis. “It is a broadly used anticoagulant, however it reasons extra primary opposed occasions than another oral drug. 1000’s of sufferers finally end up within the emergency division or medical institution on account of warfarin-induced bleeding. However we proceed to prescribe it as a result of it’s extremely efficient, reversible and affordable. So our function is to make warfarin more secure. GIFT confirmed that precision-medicine according to medical elements and 3 genes improves the security of beginning warfarin treatment.”

Sufferers within the trial have been randomly assigned to one among two teams. One team won warfarin dosing according to same old elements equivalent to age, peak and weight; the second one team used to be dosed according to those medical elements plus genetic variants. Collaborating websites within the trial integrated Washington College Faculty of Medication, Clinic for Particular Surgical procedure in New York, Intermountain Healthcare, College of Utah, and Rush College Clinical Middle.

Of the 789 sufferers who have been dosed within the conventional approach, 116 skilled no less than one opposed tournament (14.7 p.c). Of the 808 sufferers whose warfarin dosing used to be guided via genetic checking out, 87 skilled an opposed tournament (10.eight p.c). In comparison with sufferers receiving conventional warfarin dosing, sufferers dosed with the genetic means had a 27 p.c relief in opposed occasions, which used to be statistically other. The opposed occasions have been bleeding, formation of blood clots within the veins and warfarin overdoses. No affected person died all through the trial.

Previous research having a look at whether or not genetic checking out may give a boost to warfarin dosing had produced conflicting effects. Alternatively, those research have been smaller and regarded as fewer genes than GIFT. GIFT enrolled 1,600 sufferers age 65 and older at top possibility of blood clots as a result of they underwent hip- or knee-replacement surgical procedures.

Not like prior research, GIFT took under consideration genetic variants in 3 genes for 11 days of warfarin treatment. Genetic variants have been assessed on a industrial platform known as GenMarkDx. Variants in a single gene have an effect on nutrition Ok recycling. Variants in any other gene have an effect on warfarin sensitivity. Variants within the 3rd gene modify warfarin metabolism within the liver and will purpose an overdose if the dose isn’t adjusted quickly sufficient.

“There are further genetic variants that can lend a hand to lead warfarin dosing, particularly amongst sufferers with African ancestry,” Gage mentioned. At some point, we are hoping to quantify how those variants have an effect on warfarin.”

Gage additionally famous how health-care prices relate to dosing warfarin in a genetically guided approach. “Even if genetic checking out is dearer than medical dosing, the price is falling,” he mentioned. “In our find out about, we estimated that genetic checking out prices not up to $200 in line with particular person, which is not up to one month of a more moderen anticoagulant.”


Discover additional:
Genetically guided warfarin dosing lowers possibility of a few opposed occasions

Additional info:
Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez Jr. T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, DeVore B, Porche-Sorbet R, Napoli L, Merritt Ok, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V and Eby CS for the GIFT investigators. Impact of genotype-guided warfarin dosing on medical occasions and anticoagulation regulate amongst sufferers present process hip or knee arthroplasty: the GIFT randomized medical trial. Magazine of the American Clinical Affiliation. Sept. 26, 2017. DOI: 10.1001/jama.2017.11463

Magazine reference:
Magazine of the American Clinical Affiliation

Supplied via:
Washington College Faculty of Medication

Tagged with:

About author

Related Articles